Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPlastic/Reconstructive SurgeryBlue Shield CA Mastectomy Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentBlue Shield of CaliforniaPolicy 7.01.09

    Risk-Reducing Mastectomy

    Customize your policy alerts

    Sign up for blue_shield_of_california Policy 7.01.09 alerts

    Get alerted when Policy 7.01.09 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Coverage of mastectomy performed to reduce breast cancer risk in the absence of malignant disease; medically necessary for individuals at high risk and investigational for other indications.

    Policy Summary
    PayerBlue Shield of California
    PolicyRisk-Reducing Mastectomy
    Policy CodePolicy 7.01.09
    Change TypeNo material change
    Effective DateNov 1, 2026
    Next Review DateN/A
    Key ActionFor clinical review, provide history and physical and/or consultation notes documenting high risk of breast cancer, relevant familial history, and previous radiotherapy to the chest.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    ≥20%Lifetime breast cancer risk threshold
    4High-risk factor categories identified
    InvestigationalOutside high-risk criteria
    1CPT code listed
    3

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Pre-service documentation topics
    No changeAnnual review status

    Coverage Criteria

    High-risk breast cancer prevention

    May be considered medically necessary when the individual is at high risk of breast cancer.

    High-risk indication: The individual is at high risk of breast cancer.Generally lifetime risk ≥20%, or a recognized high-risk factor such as lobular carcinoma in situ, a BRCA1 or BRCA2 variant, another high-risk gene variant, or radiotherapy to the chest between 10 and 30 years of age.

    Risk assessment may require individualization using multiple risk factors.

    Extensive mammographic abnormalities

    The policy identifies this as a relevant clinical population in the evidence and clinical context.

    Extensive mammographic abnormalities: The individual has extensive mammographic abnormalities precluding excision or biopsy.Not specified

    The policy statement expressly identifies high-risk individuals as the medically necessary indication; it does not separately state the coverage status of this population in the cited policy statement.

    Non-high-risk contralateral mastectomy

    Considered investigational when high-risk criteria are not met.

    Contralateral risk-reducing mastectomy without high-risk status: The individual has breast cancer and is considering contralateral risk-reducing mastectomy but does not meet high-risk criteria.High-risk criteria not met

    This includes, but is not limited to, contralateral risk-reducing mastectomy in individuals with unilateral breast cancer who are not otherwise at high risk.

    Risk-reducing mastectomy in high-risk individuals

    May be considered medically necessary when the individual is at high risk of breast cancer.

    High-risk indication: The individual is at high risk of breast cancer.Generally lifetime risk ≥20%, or a recognized high-risk factor such as lobular carcinoma in situ, a BRCA1 or BRCA2 variant, another high-risk gene variant, or radiotherapy to the chest between 10 and 30 years of age.

    For definitions of risk levels, refer to the policy guidelines; the policy may consider individual risk factors in combination.

    Risk-reducing mastectomy may be considered medically necessary for individuals at high risk of breast cancer. All other indications are considered investigational, including, but not limited to, contralateral risk-reducing mastectomy in individuals with breast cancer who do not meet high-risk criteria.

    Risk-reducing mastectomy is investigational for indications other than high breast cancer risk. This includes contralateral risk-reducing mastectomy for individuals with breast cancer who do not meet the policy’s high-risk criteria.

    Coding

    CPTCPT
    19303Mastectomy, simple, complete
    High-risk threshold
    Lifetime breast cancer risk≥20%

    Provider Actions

    Documentation Required

    High-Risk Clinical Documentation

    Submit pre-service history and physical and/or consultation notes documenting the clinical basis for high-risk status and relevant risk history.

    • High risk of breast cancer
    • Familial history as it relates to high-risk breast cancer
    • Previous radiotherapy to the chest
    Documentation Required

    Independent Risk Counseling

    Counseling regarding cancer risks and treatment options should be provided by a qualified health professional other than the operating surgeon who is skilled in assessing cancer risk.

    • Discuss options including increased surveillance or chemoprevention

    Background

    Risk-reducing mastectomy removes breast tissue in the absence of malignant disease to reduce the likelihood of developing breast cancer in the future. It may be considered for individuals at elevated risk related to hereditary variants, lobular carcinoma in situ, prior chest radiotherapy, family history, or combinations of risk factors. Bilateral surgery may reduce the risk of a new breast cancer, while active surveillance and chemoprevention are alternatives. Contralateral risk-reducing mastectomy for individuals with unilateral breast cancer who do not otherwise meet high-risk criteria has not demonstrated a consistent survival benefit and carries surgical and reconstructive risks.

    Definitions and Abbreviations

    Risk-reducing mastectomy
    Risk-reducing mastectomyRemoval of the breast in the absence of malignant disease to reduce the risk of breast cancer occurrence.
    High risk of breast cancer
    Generally accepted thresholdA lifetime breast cancer risk of 20% or greater.
    Independent high-risk factorsLobular carcinoma in situ; a known BRCA1 or BRCA2 variant; another high-risk gene variant; or radiotherapy to the chest between 10 and 30 years of age.
    Contralateral risk-reducing mastectomy
    Contralateral risk-reducing mastectomyA unilateral mastectomy performed in an individual who has previously undergone or is currently undergoing mastectomy of the opposite breast for invasive cancer.
    Policy Summary
    PayerBlue Shield of California
    PolicyRisk-Reducing Mastectomy
    Policy CodePolicy 7.01.09
    Change TypeNo material change
    Effective DateNov 1, 2026
    Next Review DateN/A
    Key ActionFor clinical review, provide history and physical and/or consultation notes documenting high risk of breast cancer, relevant familial history, and previous radiotherapy to the chest.
    SourceLink
    On This Page
    Coverage CriteriaCodingProvider ActionsBackgroundDefinitions and Abbreviations
    Prior Authorization

    Pre-Service Documentation Required

    Before the service, submit documentation establishing the individual’s high-risk breast cancer status and the related clinical and familial history required for review.

    • Provide the required history and physical and/or consultation documentation before service

    Unsupported block type: documentation

    Denial Risk

    Non-High-Risk Indications

    Risk-reducing mastectomy is considered investigational for indications other than high breast cancer risk, including contralateral risk-reducing mastectomy in individuals with breast cancer who do not meet high-risk criteria.

    • Available evidence does not demonstrate a consistent survival benefit for contralateral risk-reducing mastectomy in individuals without high-risk criteria
    Denial Risk

    High-Risk Criteria Not Met

    An indication that does not meet the policy’s high-risk criteria is considered investigational and is not eligible for coverage as a medically necessary risk-reducing mastectomy.

    • High-risk criteria must be established in the submitted clinical documentation
    Risk-reducing mastectomy
    Risk-reducing mastectomyRemoval of the breast in the absence of malignant disease to reduce the risk of breast cancer occurrence.
    Contralateral risk-reducing mastectomy
    ProcedureMastectomy of the breast contralateral to the breast affected by unilateral breast cancer.
    PopulationIndividuals who are not otherwise at high risk.
    Contralateral breast cancer
    Contralateral breast cancer (CBC)A new primary breast cancer occurring in the opposite breast after an initial breast cancer diagnosis.
    Abbreviation
    CBCContralateral breast cancer.
    Abbreviation
    CRRMContralateral risk-reducing mastectomy.
    Abbreviation
    CPMContralateral prophylactic mastectomy.
    Abbreviation
    BRRMBilateral risk-reducing mastectomy.
    Abbreviation
    PVPathogenic variant.
    Abbreviation
    ADHAtypical ductal hyperplasia.
    Abbreviation
    ALHAtypical lobular hyperplasia.
    Abbreviation
    LCISLobular carcinoma in situ.